Details of the Drug Reposition

General Information of This Drug (ID: DMSCDY9)

• Drug Name: Mannitol (DMSCDY9)
• Synonyms: Diosmol; Hexahydroxyhexane; Invenex; Isotol; MTL; Manita; Mannazucker; Mannidex; Mannigen; Mannistol; Mannit; Mannite; Osmitrol; Osmofundin; Osmosal; Resectisol; Cordycepic acid; Cpd without stereochemical designation; Manna sugar; Mannitol [USAN]; Marine Crystal; Resectisol In Plastic Container; M0044; Mannidex 16700; Mannogem 2080; D-mannite; D-mannitol; DL-Mannitol; MANNITOL 25%; Maniton-S; Mannitol (USP); Mannitol (VAN); Mannitol 10%; Mannitol 10% In Plastic Container; Mannitol 15%; Mannitol 15% In Plastic Container; Mannitol 20%; Mannitol 20% In Plastic Container; Mannitol 5%; Mannitol 5% In Plastic Container; OSMITROL 10% IN WATER IN PLASTIC CONTAINER; OSMITROL 15% IN WATER IN PLASTIC CONTAINER; OSMITROL 20% IN WATER IN PLASTIC CONTAINER; OSMITROL 5% IN WATER IN PLASTIC CONTAINER; Osmitrol (TN); Osmitrol 10% In Water; Osmitrol 15% In Water; Osmitrol 20% In Water; Osmitrol 5% In Water; SDM No. 35; SORBITOL-MANNITOL IN PLASTIC CONTAINER; Sorbitol-Mannitol; D-Mannitol (JP15); MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER; D-(-)-Mannitol; ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D; MANNITOL 15% DEXTROSE 5% IN SODIUM CHLORIDE 0.45%; MANNITOL 5% DEXTROSE 5% IN SODIUM CHLORIDE 0.12%; (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol; (L)-Mannitol
• Therapeutic Class: Sweetening Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

7 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pseudotumor cerebri	DISLLY7S	N.A.	Approved	[1]
Cerebral edema	DIS4GHSB	8D60.1	Approved	[1]
Ocular hypertension	DISC2BT9	9C61.01	Approved	[1]
Bronchiectasis	DIS5MYEE	CA24	Approved	[2]
Cystic fibrosis	DIS2OK1Q	CA25	Approved	[1]
Renal failure	DIS070UC	GB60-GB6Z	Approved	[2]
Edema	DISJW6E6	MG29	Approved	[1]

References

• [1] Mannitol FDA Label
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 016080.